I-Mab Biopharma
IMAB
#9316
Rank
A$0.10 B
Marketcap
$1.26
Share price
-5.65%
Change (1 day)
-54.07%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$17.96 Million

According to I-Mab Biopharma's latest financial reports the company's total liabilities are A$17.96 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$26.21 M-27.07%
2022-12-31A$35.93 M1.6%
2021-12-31A$35.37 M64.02%
2020-12-31A$21.56 M-80.43%
2019-12-31A$0.11 B10.29%
2018-12-31A$99.94 M150.1%
2017-12-31A$39.96 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$18.95 M 5.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.30 B 7,146.22%๐Ÿ‡บ๐Ÿ‡ธ USA